Skip to main content

Global Subdermal Contraceptive Implants Market Growth Analysis, Business Opportunities, Future Scope and Forecast To 2026

Mar 24, 2020: The global Subdermal Contraceptive Implants market size is expected to reach USD 969.2 million by 2026, according to a new report by Grand View Research, Inc., registering a 3.2% CAGR over the forecast period. Introduction of several modern contraceptives in the market, growing awareness about various birth control methods, and high per capita income are some of the key factors driving the market for subdermal implants for birth control.
According to the Guttmacher Institute, in 2014, approximately 20 million women needed publicly funded contraceptive services. According to CDC, in 2017, nearly 46.9 million women in the U.S. were using at least one method of contraception. Subdermal implant is a long-term birth control option for women. Subdermal implants for contraception are in the form of polymer capsules or rods placed under the skin. The progestational hormone is released at a slow and stable rate, providing effective contraception for 1-5 years.
Publicly funded family planning services help women avoid or plan pregnancies. In 2012, the South Carolina Department of Health and Human Services (SCDHHS) revised the cost associated with Medicaid payment policy for immediate postpartum insertion of Long-Acting Reversible Contraception (LARC). Under this new reimbursement policy, providers are allowed to bill for the insertion procedure and the cost of an IUD or an implant, in addition to the Diagnosis Related Group (DRG) by using J-codes with a family planning modifier.
Implants are the most widely used contraceptive methods by women in sub-Saharan Africa owing to public-private partnerships between manufacturers, donors, governments, and international agencies, which helps lower commodity cost and increase product availability. Contraceptive usage has increased in South Africa, Malawi, and Rwanda. According to PLOS.org, in Malawi, the use of the Long-acting Reversible Contraception (LARC) method reached 10.21% in urban areas in 2016 and 9.66% in rural areas. In 2012, an initiative called Family Planning 2020 (FP2020) was launched to give 120 million women access to modern contraceptive methods by 2020.
Further key findings from the report suggest:
• North America held the maximum share in the market for subdermal implants for contraception in 2018. This can be attributed to growing number of unwanted pregnancies, increased government initiatives in favor of contraception, and rising unmet needs
• Strong economic growth in countries such as China, India, and Singapore, increasing awareness about contraceptives and STIs, and rising disposable income are expected to boost the Asia Pacific market in the coming years
• Rapid population growth is a major concern in sub-Saharan African countries; the region’s population growth is projected to account for more than half of the global population growth by 2050. This could have a positive impact on the uptake of subdermal implants for birth control
• Some of the key subdermal contraceptive implants market players are Shanghai Dahua Pharmaceutical Co., Ltd.; Merck & Co., Inc.; and Bayer AG. In February 2018, Shanghai Dahua Pharmaceutical Co., Ltd. and DKT International entered into an agreement to market Levoplant at a reduced price of USD 6.90 per unit in 69 countries.
Table of Contents
Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Regional Scope
1.1.2 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.2 Variable analysis
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective – 1
1.10.2 Objective – 2
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.2.1 Region
2.3 Competitive Insights
Chapter 3 Market Variables, Trends & Scope
3.1 Market Lineage outlook
3.1.1 Parent market outlook
3.2 Market Segmentation
3.3 Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Rise in the number of initiatives to promote contraceptive methods
3.3.1.2 Increasing number of unwanted pregnancies
3.3.2 Market restraint analysis
3.3.2.1 Rapidly aging population and rising prevalence of infertility
3.3.2.2 Lack of awareness and adverse effects of contraceptive implants
3.4 Business Environment Analysis Tools
3.4.1 Porter’s five forces analysis
3.4.2 PESTEL analysis
3.5 Major Deals & Strategic Alliances Analysis
3.6 Pipeline Analysis
Continued………………….

To See More Reports of This Category by Radiant Insights:
https://latestmarkettrends.news.blog
About Radiant Insights:Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. It assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. The Organization has a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
Media Contact:Company Name: Radiant Insights, Inc
Contact Person: Michelle Thoras
Email: sales@radiantinsights.com
Phone: (415) 349-0054
Address: 201 Spear St #1100, Suite #3036
City: San Francisco
State: California
Country: United States
For more information, Visit: https://marketsandtrendsreport.blogspot.com/

Comments

Download Free Popular Research

Global Food Grade & Pharma Grade Calcium Phosphate Market Will Generate Maximum Revenue From 2020 To 2025

  Nov 05 2020:   The global   Food Grade & Pharma Grade Calcium Phosphate market   was valued at $XX million in 2018, and Radiant Research analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028. This report provides detailed historical analysis of global market for Food Grade & Pharma Grade Calcium Phosphate from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Food Grade & Pharma Grade Calcium Phosphate market. To Request A Sample Copy Of This Report @:     https://www.radiantinsights.com/research/2013-2028-report-on-global-food-grade-and-pharma-grade-calcium-phosphate-market/request-sample Leading players of Food Grade & Pharma Grade Calcium Phosphate including: Innophos Prayon ICL PP Chengxing Industrial Hens Budenheim Tianjia Chem Hindus

Global IT Equipment Disposal Market Analysis, Size, Share, Growth, Trends and Forecast 2018-2028: Radiant Insights Inc

April 12, 2019:  The global IT Equipment Disposal market was valued at $XX million in 2017, and Radiant Research analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2017 and 2028. To Request A Sample Copy Of This Report @: https://www.radiantinsights.com/research/2013-2028-report-on-global-it-equipment-disposal-market/request-sample This report provides detailed historical analysis of global market for IT Equipment Disposal from 2013-2018 and provides extensive market forecasts from 2018-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the IT Equipment Disposal market. To Browse Full Research Report @: https://www.radiantinsights.com/research/2013-2028-report-on-global-it-equipment-disposal-market Leading players of IT Equipment Disposal including: Eletronic Recyclers International Sims Recycling Solutions Waste Manag

Cervical Cancer Diagnostic Market Worth About USD 12 billion By 2024

  Cervical Cancer Diagnostic Market size is anticipated to reach USD 12 billion by 2024. Cervical cancer is caused due to uncontrolled cell division of cancerous or abnormal cell growth in the cervix region. The factors that propel the growth of the cervical cancer diagnostics market include increase in aging female population, rise in the awareness programs for cervical cancer screening, high occurrence rate, and rapid adoption of technology. Moreover, increasing consciousness among the population regarding prevention, care, and treatment of cervical cancer, and availability of advanced and variety of treatment are likely to offer impetus to the market. On the other hand, there are factors that may hamper the growth of the market including lack of awareness related to cervical cancer protection, and changes in regulatory guidelines for cervical cancer screening. Cervical cancer diagnostics industry is anticipated to grow at a significant CAGR of 5.9% in the upcoming period as the sc